Delivered-To: oc.tjphuhs@gmail.com Received: by 2002:a05:6400:a10c:b0:2cf:41ef:c6c3 with SMTP id k12csp73154eck; Fri, 24 Apr 2026 10:29:01 -0700 (PDT) X-Received: by 2002:a05:690c:60c3:b0:7a2:1f26:3d6a with SMTP id 00721157ae682-7b9ed00a78dmr341725507b3.45.1777051741431; Fri, 24 Apr 2026 10:29:01 -0700 (PDT) ARC-Seal: i=1; a=rsa-sha256; t=1777051741; cv=none; d=google.com; s=arc-20240605; b=Xj6JQNhEBBB36H7Ps9FNC6RAOmknEvYhbbX81VboZAGw1l6Ksa90NSSDIsu8lj64Bg p6z8w126CZI0mg88xXaQ3zcuroVtqQ11I4lZvz772o6NT/KKJYKBecUzZWAZ52LP1ZtF EvH+Wn3vWCBwT00A/W1rjL1cTiss7u+SCVyTFpBmnCcf7WbzITkOK2H1xG3LtoDEhD/n fPBfVp2tolGk01uZwLdlyW9FGC3ce1ewiukeQUZH4rz0PjVHy8+ZUlrs3lC087pccXqu WRiOwm4+7Fc021SMpdFhHs1dTIwEe3x7/fKeF6legl1DMhPRzzHlG3bU3DpeCF0vY1QJ 8taA== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=mime-version:subject:references:in-reply-to:message-id:to:from:date :dkim-signature; bh=iDQqD+64qDJUlvRrV49qlGB5+CW4nLY1xvyZo6BV3x4=; fh=F6Qtq/PC/9aW+A0Z/30DYnuZeFJIQSXKTJRrYsjMofs=; b=cOL1Gx1W5lVG7yfLje2JnsuJE6dLkvuDrRGa1G/WlozebKu7FoZt18fNm0m8k4rPFK 5+6sTOJK8jGeO6ql1JgEXJaiSbdCVTj9PUwB4qlBvry0SBjIVpTLknqcy1T2E3/y7hSN whbAlRQy7Kckz5VDkGAir15YjWphpgnCFGNZ8konJNF+vp2wX979eSWuWNtdpmTzPqp9 aWqXaJF9KNTDxH99FBXCodVRh6zAKNLy7bVXvqYgcyp/sVxKLJidJrfNdcS47F4Y09PQ 3cJI/Lx0hZT3t55c1+2vwRo7GyMvy35p3WXzt7uGMzzDla9Jx+vM2nLshjPyiFw+GRWJ 3Ovw==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@gmail.com header.s=20251104 header.b=lBy467Ij; spf=pass (google.com: domain of tjphuhs@gmail.com designates 209.85.220.41 as permitted sender) smtp.mailfrom=tjphuhs@gmail.com; dmarc=pass (p=NONE sp=QUARANTINE dis=NONE) header.from=gmail.com; dara=pass header.i=@gmail.com Return-Path: Received: from mail-sor-f41.google.com (mail-sor-f41.google.com. [209.85.220.41]) by mx.google.com with SMTPS id 00721157ae682-7b9ee86f1c4sor121396417b3.1.2026.04.24.10.29.01 for (Google Transport Security); Fri, 24 Apr 2026 10:29:01 -0700 (PDT) Received-SPF: pass (google.com: domain of tjphuhs@gmail.com designates 209.85.220.41 as permitted sender) client-ip=209.85.220.41; Authentication-Results: mx.google.com; dkim=pass header.i=@gmail.com header.s=20251104 header.b=lBy467Ij; spf=pass (google.com: domain of tjphuhs@gmail.com designates 209.85.220.41 as permitted sender) smtp.mailfrom=tjphuhs@gmail.com; dmarc=pass (p=NONE sp=QUARANTINE dis=NONE) header.from=gmail.com; dara=pass header.i=@gmail.com DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=gmail.com; s=20251104; t=1777051740; x=1777656540; dara=google.com; h=mime-version:subject:references:in-reply-to:message-id:to:from:date :from:to:cc:subject:date:message-id:reply-to; bh=iDQqD+64qDJUlvRrV49qlGB5+CW4nLY1xvyZo6BV3x4=; b=lBy467IjUysglViC0penLCj/m7XcqhMpEtBHcN5FY6KQdUmP9qgv9Mg8NT6AYUSy3D GmpTr5luNdXyGda1UH3EUT34CvMVSSZtyZLHFVqUFmVvcZkgNjm3veD8BpSIrS9LPdl0 SqvSVzcfYk5S8KwxPDUFoNSw4aSnXHupGTCTynm9HJexRR4OXppqmrgu/YK8xp+P5639 Oz5QPSwexO4tsl76fc8vUYxQ447xXmyLL3UZOw8kIIjQP/VSbNzoArn2rl+DF/HxRMNq IPkva64tgKneDsa6dv3Sa5TGF/nbUHF5c0p7sD12A64diGNQQnbend+EQDA6NmFBJcuB rNwQ== X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=1e100.net; s=20251104; t=1777051740; x=1777656540; h=mime-version:subject:references:in-reply-to:message-id:to:from:date :x-gm-gg:x-gm-message-state:from:to:cc:subject:date:message-id :reply-to; bh=iDQqD+64qDJUlvRrV49qlGB5+CW4nLY1xvyZo6BV3x4=; b=Qadi8SSFYUTvBD4RrdVfhHxG/+s8FY87Zw7iKbZjVdjY5CM5zGY6buPzHvp40dc/Cn Lb7bwRTUj58igdf9vSk2wYMp3uv1g67clb6oPOwXqVqLSHoIZnZgh8hlCIf7m5Zdt4aJ TJ+00j41x77952hNhZ/NwpKfmqND2pFu08/7JbTydvcZkd+k+iQGKRmpOJvXEdZeTJK+ 2BO8J9OK4rWuOK37OMeJBiuyGi0xItWQidKJ1IlvNhLIRCEjIPaejVw8kpEgkiVajIqu qjuOa+xzzfxPgzxh1dR1PC3KVnc5ZjScyftJpfIRTGNpLPxFVnKvMDgI9/yU7+esY8mD T80A== X-Gm-Message-State: AOJu0YwQ1P0Qju8SF1FTSoy36Igz9Rb0FB/x/c/SaxfxrSzvoN7vAVqR Zbmt62f7Qm71pRWpxwqeUgrruZqhYQ0AtT3KwuRRExo4OHtBiM2dPYyyZEdAeA== X-Gm-Gg: AeBDies9A7m/py8mn4xiDEs862setiauYRkgMTndHqi8lrRNKwdDwL1LapP/ckBL8gD +rFy09ClIFdoMrdt1TJinLrtxcqEg3VTMolG8q6ZFKTqh/OEPhqRnEbN/uKDF08j4AsfO0S1aJm gqjK8hxo6PuVhCEBY1fwz1zYSQGamVyaQzIPNfK5R/A0X4EtNaxQucQiBqxMXGVgEmddtmPamTy Ij3cN3KKLpzA0jHXv4ywJhLwY+MjJRerbA8drswE54QMsfSl1T1U54bsvsCY4FEn/AMLQIOAkvl DsgP4dxJDYlhZx4o7GQ1cgpJcN+i42SbODFSRn3oESeGg76q19T4BqD7YOxkaUlomDGRFoVA28h 83sTe72BFxpqjTE9w8hKQ/OduA+tBEtaU2Jx/tmc8KJLy3BzazaDucUBMuy1YJdBt+hv6cLRiwQ uroyhb46VfMKxaU45TLzilFR4s7tRkT/jGT3ibYYt9qbPDknq5f4nRC2wKBn2Yeom0brblIDqFm gZLiH8GZKRj X-Received: by 2002:a05:690c:680f:b0:79b:e1e1:9e4d with SMTP id 00721157ae682-7b9ecfdb0c9mr352822197b3.40.1777051739676; Fri, 24 Apr 2026 10:28:59 -0700 (PDT) Return-Path: Received: from [2607:fb91:8c1b:8c8:5078:8109:100:0] ([2607:fb91:8c1b:8c8:5cd6:2797:a597:d454]) by smtp.gmail.com with ESMTPSA id 00721157ae682-7b9ee89ac50sm94571417b3.7.2026.04.24.10.28.57 for (version=TLS1_2 cipher=ECDHE-ECDSA-AES128-GCM-SHA256 bits=128/128); Fri, 24 Apr 2026 10:28:59 -0700 (PDT) Date: Fri, 24 Apr 2026 13:28:54 -0400 From: tjphuhs@gmail.com To: "=?utf-8?Q?oc.tjphuhs=40gmail.com?=" Message-ID: <18ba30b9-8783-4aa6-9ab1-0f160c06c2c7@Spark> In-Reply-To: <20260424171804.3.48c0d9c9f777b28c@mg-d1.substack.com> References: <20260424171804.3.48c0d9c9f777b28c@mg-d1.substack.com> Subject: Fwd: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial Research Compounds X-Readdle-Message-ID: 18ba30b9-8783-4aa6-9ab1-0f160c06c2c7@Spark MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="69eba858_60d29b7d_2e86" --69eba858_60d29b7d_2e86 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: quoted-printable Content-Disposition: inline ---------- =46orwarded message ---------- =46rom: Derek from Research Radar Date: Apr 24, 2026 at 1:18=E2=80=AFPM -0400 To: tjphuhs=40gmail.com Subject: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitoch= ondrial Research Compounds > I get a lot of questions about MOTS-c versus NAD+, and one of the most = common is which one research protocols should implement first. > =CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0= =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2= =AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2= =A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87= =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F= =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80= =87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD= =8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2= =80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD= =CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0= =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2= =AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2= =A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87= =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F= =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80= =87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD= =8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2= =80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD= =CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0= =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2= =AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2= =A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87= =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F= =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80= =87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD= =8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2= =80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD= =CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0= =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2= =AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2= =A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87= =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F= =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80= =87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD= =8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2= =80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD= =CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0= =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2= =AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2= =A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87= =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F= =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80= =87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD= =8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2= =80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD= =CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0= =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2= =AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2= =A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87= =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F= =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80= =87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD= =8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2= =80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD= =CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0= =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2= =AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2= =A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87= =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F= =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80= =87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD= =8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2= =80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD= =CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0= =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2= =AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2= =A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87= =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F= =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80= =87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD= =8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2= =80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD= =CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0= =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2= =AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2= =A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87= =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F= =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80= =87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD= =8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2= =80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD= =CD=8F =C2=A0 =E2=80=87 =C2=AD=CD=8F =C2=A0 =E2=80=87 =C2=AD > =46orwarded this email=3F Subscribe here for more > MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochondrial= Research Compounds > Derek > Apr 24 > > READ IN APP > > I get a lot of questions about MOTS-c versus NAD+, and one of the most = common is which one research protocols should implement first. > This post breaks down what each one actually does, how they differ, and= gives you a simple decision tree to think through which one fits your re= search interests. > > A note on framing: Everything here is strictly for research use only.= These compounds are not for human consumption. Nothing below is medical = advice. This is educational content to help you understand what the resea= rch literature says about these molecules and how they function at the ce= llular level. > Upgrade to paid > The 30-Second Version > MOTS-c is a small peptide (16 amino acids) that mitochondria produce. T= hink of it as a signaling molecule that tells cells to burn fuel more eff= iciently, improve insulin sensitivity, and handle metabolic stress better= . > NAD+ (nicotinamide adenine dinucleotide) is a coenzyme =E2=80=94 a help= er molecule cells use for hundreds of reactions, especially energy produc= tion and DNA repair. It=E2=80=99s not a peptide. It=E2=80=99s a fundament= al molecule every living cell needs to function. > One is a signal. The other is fuel for the machinery. That distinction = matters. > What Are Mitochondria, Really=3F > Before going further, a quick primer because everything below depends o= n it. > Mitochondria are the energy factories inside nearly every cell. They ta= ke nutrients and turn them into ATP, the energy currency cells actually u= se to do work. They also handle other jobs: regulating cell death, managi= ng calcium, producing heat, and sending stress signals to the rest of the= organism. > With age, mitochondria get less efficient. They produce less ATP, more = waste (reactive oxygen species), and their signaling gets noisier. A lot = of what gets called =E2=80=9Caging=E2=80=9D at the cellular level is real= ly mitochondrial decline. > Both MOTS-c and NAD+ are studied for their effects on this system, but = from completely different angles. > MOTS-c: The Mitochondrial Messenger > MOTS-c stands for =E2=80=9CMitochondrial Open Reading =46rame of the 12= S rRNA type-c.=E2=80=9D Mouthful, I know. Here=E2=80=99s what matters. > Where it comes from. Unlike most peptides which are encoded in nuclear = DNA, MOTS-c is encoded in mitochondrial DNA. Mitochondria produce it them= selves. It belongs to a small class called mitochondrial-derived peptides= (MDPs). > What the research shows: > > =E2=80=A2 > Activates AMPK, the master energy sensor in cells. When AMP= K is active, cells shift into =E2=80=9Cburn fuel, don=E2=80=99t store it=E2= =80=9D mode. > =E2=80=A2 > Improves insulin sensitivity in preclinical models, meaning= muscle cells pull glucose out of circulation more efficiently. > =E2=80=A2 > Appears to protect against metabolic stress in rodent studi= es (high-fat diet models). > =E2=80=A2 > Levels naturally decline with age, which some researchers t= hink contributes to age-related metabolic dysfunction. > > > Mechanism in one sentence: MOTS-c is a signal that tells cells to bur= n fuel efficiently and handle metabolic stress better. > NAD+: The Universal Coenzyme > NAD+ isn=E2=80=99t a peptide. It=E2=80=99s a dinucleotide =E2=80=94 a s= mall molecule that every cell uses constantly. Life isn=E2=80=99t possibl= e without it. > Where it comes from. Cells synthesize NAD+ continuously and recycle it = thousands of times a day. Unlike MOTS-c, which is a targeted signaling pe= ptide, NAD+ is involved in a huge range of cellular processes at once. > What the research shows: > > =E2=80=A2 > Required for the electron transport chain, the final step o= f ATP production in mitochondria. > =E2=80=A2 > =46uels sirtuins (SIRT1-7), a family of enzymes involved in= DNA repair, gene expression, and stress response. > =E2=80=A2 > Required for PARP enzymes, which repair DNA damage. > =E2=80=A2 > Levels drop significantly with age =E2=80=94 some research = shows 50%+ decline by middle age. > =E2=80=A2 > Studied heavily in longevity, neuroprotection, and recovery= -related literature. > > > Mechanism in one sentence: NAD+ is the coenzyme that powers energy pr= oduction, DNA repair, and longevity-related enzyme pathways. > The Key Differences at a Glance > MOTS-c is a signal. NAD+ is substrate. A thermostat versus the fuel in = the furnace. MOTS-c tells the system what to do. NAD+ is what the system = uses to do it. > MOTS-c targets metabolism specifically. Insulin sensitivity, glucose ha= ndling, AMPK signaling. NAD+ touches almost everything cells do, which ma= kes it broader but also less targeted. > MOTS-c is a peptide. NAD+ is a coenzyme. Totally different classes of m= olecules. > MOTS-c research is relatively young. Discovered in 2015. The literature= is growing but still thin compared to NAD+, which has been studied since= the early 1900s. > The Decision Tree > Here=E2=80=99s a walkthrough to help you think about which direction ma= tches your research interests. Read through top to bottom, stop at the fi= rst question where the answer is yes. > 1. Is your focus primarily metabolic pathways=3F (glucose handling, ins= ulin sensitivity, AMPK signaling) > =E2=86=92 MOTS-c is more targeted. =46ocus area: AMPK activation litera= ture. Key models: high-fat diet rodent studies. > 2. Is your focus primarily general cellular energy pathways=3F (ATP pro= duction, mitochondrial function broadly) > =E2=86=92 NAD+ sits upstream of energy production. =46ocus area: electr= on transport chain. Key models: age-related NAD+ decline studies. > 3. Is your focus primarily longevity, DNA repair, or sirtuin biology=3F= > =E2=86=92 NAD+ is the direct play here. MOTS-c doesn=E2=80=99t directly= feed these pathways. =46ocus area: SIRT1-7, PARP enzymes. > 4. Is your focus primarily metabolic stress response=3F (how cells resp= ond to nutrient overload or metabolic challenge) > =E2=86=92 MOTS-c has specific literature here. =46ocus area: mitochondr= ial-derived peptide signaling. > 5. Broad mitochondrial interest without a specific target yet=3F > =E2=86=92 NAD+ has a larger body of literature to start with. MOTS-c be= comes a more targeted follow-up once the research question gets sharper. > Common Beginner Questions > Do MOTS-c and NAD+ overlap in mechanism=3F > Not directly. MOTS-c activates AMPK signaling, which is a metabolic swi= tch. NAD+ is a coenzyme that powers entirely different enzyme families (s= irtuins, PARPs) and sits at the core of ATP production. Both end up touch= ing =E2=80=9Cmitochondrial function,=E2=80=9D but through different doors= . That=E2=80=99s why the research questions they fit are different. > Which one has stronger preclinical evidence=3F > NAD+ has a much longer and broader literature =E2=80=94 it=E2=80=99s be= en studied for over a century, and the age-related decline data is well r= eplicated. MOTS-c is newer (2015 discovery) and the literature is narrowe= r, but the AMPK and insulin sensitivity findings in rodent models have be= en replicated by multiple groups. Different maturity levels, both with in= teresting data. > Why do I see both called =E2=80=9Canti-aging=E2=80=9D=3F > Because mitochondrial decline is one of the hallmarks of aging, and bot= h compounds intersect with that decline =E2=80=94 just at different point= s. MOTS-c at the signaling layer, NAD+ at the substrate layer. The =E2=80= =9Canti-aging=E2=80=9D framing in marketing is usually oversimplified. Th= e research is more nuanced and mostly preclinical. > Can they be studied together=3F > Mechanistically they don=E2=80=99t conflict, and there=E2=80=99s some t= heoretical rationale for why they might be complementary (signal plus sub= strate). But from a research design standpoint, studying both at once mea= ns you can=E2=80=99t tell which compound is driving any observed effect. = One variable at a time is cleaner. Study one, document carefully, then co= nsider the other. > What should I read first before getting deeper into either=3F > =46or MOTS-c: the original 2015 Lee et al. paper in Cell Metabolism is = the foundational read. =46or NAD+: the broader sirtuin literature and mit= ochondrial bioenergetics reviews are good starting points. Get familiar w= ith the mechanisms before getting into protocol debates. > The Honest Take > Neither of these is a magic bullet. The research on both is genuinely i= nteresting, but a lot of the marketing around them is ahead of the eviden= ce. > If you=E2=80=99re new and trying to decide where to focus, get very cle= ar about what you=E2=80=99re actually trying to study. =E2=80=9CEnergy=E2= =80=9D is too vague. =E2=80=9CAMPK signaling in the context of metabolic = stress=E2=80=9D or =E2=80=9Csirtuin activity in age-related cellular decl= ine=E2=80=9D is specific enough to tell which compound=E2=80=99s literatu= re makes more sense to dig into. > The worst version of research is grabbing whatever=E2=80=99s on sale an= d hoping something happens. The best version is picking one compound, get= ting familiar with the actual mechanism, and building a research question= narrow enough that the data you collect can actually answer it. > Pick the one that matches your question. That=E2=80=99s how you actuall= y learn. > If this was useful, consider subscribing =E2=80=94 I publish breakdowns= like this regularly, along with vendor vetting notes, COA walkthroughs, = and new research summaries. > Research use only. Not for human consumption. Educational content cover= ing what the scientific literature says about these compounds. Always ver= ify COAs on anything you source and stick to vetted vendors with third-pa= rty testing. > Upgrade to paid > You're currently a free subscriber to Research Radar. =46or the full ex= perience, upgrade your subscription. > Upgrade to paid > > Share > > > Like > Comment > Restack > > =C2=A9 2026 Derek Pruski > 548 Market Street PMB 72296, San =46rancisco, CA 94104 > Unsubscribe --69eba858_60d29b7d_2e86 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable Content-Disposition: inline
---------- =46orwarded message ----= ------
=46rom: Derek from Research Radar <derekpruski=40substack.com&g= t;
Date: Apr 24, 2026 at 1:18=E2=80=AFPM -0400
To: tjphuhs=40gmail.com
Subject: MOTS-c vs NAD+: The Beginner's Guide to Understanding Two= Mitochondrial Research Compounds

3D=22=22
I get a lot of questions about MOTS-c versus NAD+, and one of th= e most common is which one research protocols should implement first.
=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23= 160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80= =87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD= =CD=8F &=23160; =E2=80=87 =C2=AD=CD=8F &=23160; =E2=80=87 =C2=AD
=46orwarded this email=3F Subscribe here for more

MOTS-c vs NAD+: The Beginner's Guide to Understanding Two Mitochon= drial Research Compounds

Derek
&=23160;=
3D=22=22
3D=22=22=
3D=22=22
3D=22=22
READ IN APP3D=
&=23160;=

I get a lot of questions about MOTS-c ve= rsus NAD+, and one of the most common is which one research protocols sho= uld implement first.

This post breaks down what each one actually does, how= they differ, and gives you a simple decision tree to think through which= one fits your research interests.

A note on framing: = Everything here is strictly for research use only. These compounds = are not for human consumption. Nothing below is medical advice. This is e= ducational content to help you understand what the research literature sa= ys about these molecules and how they function at the cellular level.

Upgrade t= o paid

The 30-Second Version

MOTS-c is a small peptide (16 a= mino acids) that mitochondria produce. Think of it as a signaling molecul= e that tells cells to burn fuel more efficiently, improve insulin sensiti= vity, and handle metabolic stress better.

NAD+ (nicotinamide adenine dinu= cleotide) is a coenzyme =E2=80=94 a helper molecule cells use for hundred= s of reactions, especially energy production and DNA repair. It=E2=80=99s= not a peptide. It=E2=80=99s a fundamental molecule every living cell nee= ds to function.

One is a signal. T= he other is fuel for the machinery. That di= stinction matters.

What Are Mitochondria, Really=3F=

Before going further, a quick primer because everythin= g below depends on it.

Mitochondria are the energy factories inside nearly ev= ery cell. They take nutrients and turn them into ATP, the energy currency= cells actually use to do work. They also handle other jobs: regulating c= ell death, managing calcium, producing heat, and sending stress signals t= o the rest of the organism.

With age, mitochondria get less efficient. They produc= e less ATP, more waste (reactive oxygen species), and their signaling get= s noisier. A lot of what gets called =E2=80=9Caging=E2=80=9D at the cellu= lar level is really mitochondrial decline.

Both MOTS-c and NAD+ are studied for their effects on = this system, but from completely different angles.

MOTS-c: The Mitochondrial Messen= ger

MOTS-c stands for =E2=80=9CMitochondrial Open Reading = =46rame of the 12S rRNA type-c.=E2=80=9D Mouthful, I know. Here=E2=80=99s= what matters.

Where it comes from. Unlike mos= t peptides which are encoded in nuclear DNA, MOTS-c is encoded in mitocho= ndrial DNA. Mitochondria produce it themselves. It belongs to a small cla= ss called mitochondrial-derived peptides (MDPs).

What the research shows:

  • Activ= ates AMPK, the master energy sensor in cells. When AMPK is active, cells = shift into =E2=80=9Cburn fuel, don=E2=80=99t store it=E2=80=9D mode.

  • Impro= ves insulin sensitivity in preclinical models, meaning muscle cells pull = glucose out of circulation more efficiently.

  • Appea= rs to protect against metabolic stress in rodent studies (high-fat diet m= odels).

  • Level= s naturally decline with age, which some researchers think contributes to= age-related metabolic dysfunction.

Mechanism in one sentence: MOTS-c is a signal that tells cells to burn fuel efficientl= y and handle metabolic stress better.

NAD+: The Universal Coenzyme

NAD+ isn=E2=80=99t a peptide. It=E2=80=99s a dinucleot= ide =E2=80=94 a small molecule that every cell uses constantly. Life isn=E2= =80=99t possible without it.

Where it comes from. Cells synt= hesize NAD+ continuously and recycle it thousands of times a day. Unlike = MOTS-c, which is a targeted signaling peptide, NAD+ is involved in a huge= range of cellular processes at once.

What the research shows:

  • Requi= red for the electron transport chain, the final step of ATP production in= mitochondria.

  • =46ue= ls sirtuins (SIRT1-7), a family of enzymes involved in DNA repair, gene e= xpression, and stress response.

  • Requi= red for PARP enzymes, which repair DNA damage.

  • Level= s drop significantly with age =E2=80=94 some research shows 50%+ decline = by middle age.

  • Studi= ed heavily in longevity, neuroprotection, and recovery-related literature= .

Mechanism in one sentence: NAD+ is the coenzyme that powers energy production, DNA rep= air, and longevity-related enzyme pathways.

The Key Differences at a Glance<= /h2>

MOTS-c is a signal. NAD+ is substrate. A thermostat versus the fuel in the furnace. MOTS-c tells the sys= tem what to do. NAD+ is what the system uses to do it.

MOTS-c targets metabolism specifically. Insulin sensitivity, glucose handling, AMPK signaling. NAD+ touc= hes almost everything cells do, which makes it broader but also less targ= eted.

MOTS-c is a peptide. NAD+ is a coenzyme. Totally different classes of molecules.

MOTS-c research is relatively young. = Discovered in 2015. The literature is growing but still thin compar= ed to NAD+, which has been studied since the early 1900s.

The Decision Tree

Here=E2=80=99s a walkthrough to help you think about w= hich direction matches your research interests. Read through top to botto= m, stop at the first question where the answer is yes.

3D=22=22

1. Is your focus primarily metabolic pathways=3F= (glucose handling, insulin sensitivity, AMPK s= ignaling)

=E2=86=92 MOTS-c is more targeted= . =46ocus area: AMPK activation literature. Key models: hi= gh-fat diet rodent studies.

2. Is your focus primarily general cellular en= ergy pathways=3F (ATP production, mitochondrial= function broadly)

=E2=86=92 NAD+ sits upstream of e= nergy production. =46ocus area: electron transport chain. = Key models: age-related NAD+ decline studies.

3. Is your focus primarily longevity, DNA repa= ir, or sirtuin biology=3F

=E2=86=92 NAD+ is the direct play= here. MOTS-c doesn=E2=80=99t directly feed these pathways= . =46ocus area: SIRT1-7, PARP enzymes.

4. Is your focus primarily metabolic stress re= sponse=3F (how cells respond to nutrient overlo= ad or metabolic challenge)

=E2=86=92 MOTS-c has specific lit= erature here. =46ocus area: mitochondrial-derived peptide = signaling.

5. Broad mitochondrial interest without a spec= ific target yet=3F

=E2=86=92 NAD+ has a larger body = of literature to start with. MOTS-c becomes a more targete= d follow-up once the research question gets sharper.

Common Beginner Questions

Do MOTS-c and NAD+ overlap in mechanism=3F

Not directly. MOTS-c activates AMPK signaling, which i= s a metabolic switch. NAD+ is a coenzyme that powers entirely different e= nzyme families (sirtuins, PARPs) and sits at the core of ATP production. = Both end up touching =E2=80=9Cmitochondrial function,=E2=80=9D but throug= h different doors. That=E2=80=99s why the research questions they fit are= different.

Which one has stronger preclinical evidence=3F=

NAD+ has a much longer and broader literature =E2=80=94= it=E2=80=99s been studied for over a century, and the age-related declin= e data is well replicated. MOTS-c is newer (2015 discovery) and the liter= ature is narrower, but the AMPK and insulin sensitivity findings in roden= t models have been replicated by multiple groups. Different maturity leve= ls, both with interesting data.

Why do I see both called =E2=80=9Canti-aging=E2= =80=9D=3F

Because mitochondrial decline is one of the hallmarks = of aging, and both compounds intersect with that decline =E2=80=94 just a= t different points. MOTS-c at the signaling layer, NAD+ at the substrate = layer. The =E2=80=9Canti-aging=E2=80=9D framing in marketing is usually o= versimplified. The research is more nuanced and mostly preclinical.

Can they be studied together=3F

Mechanistically they don=E2=80=99t conflict, and there= =E2=80=99s some theoretical rationale for why they might be complementary= (signal plus substrate). But from a research design standpoint, studying= both at once means you can=E2=80=99t tell which compound is driving any = observed effect. One variable at a time is cleaner. Study one, document c= arefully, then consider the other.

What should I read first before getting deeper= into either=3F

=46or MOTS-c: the original 2015 Lee et al. paper= in Cell Metabolism is the foundational read. =46or= NAD+: the broader sirtuin literature and mitochondrial bioenergetics rev= iews are good starting points. Get familiar with the mechanisms before ge= tting into protocol debates.

The Honest Take

Neither of these is a magic bullet. The research on bo= th is genuinely interesting, but a lot of the marketing around them is ah= ead of the evidence.

If you=E2=80=99re new and trying to decide where= to focus, get very clear about what you=E2=80=99re actual= ly trying to study. =E2=80=9CEnergy=E2=80=9D is too vague.= =E2=80=9CAMPK signaling in the context of metabolic stress=E2=80=9D or =E2= =80=9Csirtuin activity in age-related cellular decline=E2=80=9D is specif= ic enough to tell which compound=E2=80=99s literature makes more sense to= dig into.

The worst version of research is grabbing whatever=E2=80= =99s on sale and hoping something happens. The best version is picking on= e compound, getting familiar with the actual mechanism, and building a re= search question narrow enough that the data you collect can actually answ= er it.

Pick the one that matches your question. That=E2=80=99= s how you actually learn.

If this was useful, consider subscribing =E2=80=94= I publish breakdowns like this regularly, along with vendor vetting note= s, COA walkthroughs, and new research summaries.

Research use only. Not for human consumption. Educ= ational content covering what the scientific literature says about these = compounds. Always verify COAs on anything you source and stick to vetted = vendors with third-party testing.

Upgrade t= o paid

You're= currently a free subscriber to Research Radar. =46or the full experience, upgrade your subscription.

Up= grade to paid

&=23160;=
3D=22=22Share
&=23160;=
&=23160;=
3D=22=22Like
3D=Comment
3D=22=22Restack
&=23160;=

=C2=A9 2026 Derek Pruski
548 Market Street PMB 72296, San =46rancisco, CA 94104
Unsubscribe

3D=22Start
3D=3D=22=22
--69eba858_60d29b7d_2e86--